SecBot SecBot
SECBOTREPLAY Home › Report › VOR

VOR · Vor Biopharma announced a private placement of 5,338,078 shares at…

Vor Biopharma · PRESS-RELEASE filed Mar 27, 2026 at 08:00 ET

At the news

NEUTRALIMPACT 5/10

PRESS-RELEASE filed Mar 27, 2026 at 08:00 ET

Vor Biopharma announced a private placement of 5,338,078 shares at $14.05 per share, raising approximately $75 million in gross proceeds. The financing, led by new investor TCGX, will be used to advance clinical development of telitacicept in myasthenia gravis and primary Sjögren’s disease, among other corporate purposes.

  • Vor Biopharma is conducting a private placement of 5,338,078 shares at $14.05 per share.
  • Gross proceeds are expected to be approximately $75 million, before expenses.
  • The financing is led by new investor TCGX; no placement agent was used.
  • Proceeds will fund Phase 3 trials in myasthenia gravis and primary Sjögren’s disease, business development, and general corporate purposes.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access